High-dose-rate brachytherapy – a novel treatment approach for primary clear cell adenocarcinoma of male urethra

The incidence of male urethral cancer is rare with age preponderance of 50 to 60 years. The standard management approach is surgery. Here, we present a novel treatment approach for male urethral cancer. Thirty-six year old male, case of primary clear cell adenocarcinoma of urethra who refused surger...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Shirley, Pal, Mahendra, Bakshi, Ganesh, Ghadi, Yogesh G., Menon, Santosh, Murthy, Vedang, Mahantshetty, Umesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499518/
https://www.ncbi.nlm.nih.gov/pubmed/26207115
http://dx.doi.org/10.5114/jcb.2015.52316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499518/
https://www.ncbi.nlm.nih.gov/pubmed/26207115
http://dx.doi.org/10.5114/jcb.2015.52316

Ejemplares similares